-
1.MODULATION OF MRTF-A ACTIVITY IN PATHOLOGIC FIBROSIS AND WOUND HEALING 有权
Title translation: 调节MRTF-A活动在病理性纤维化和创伤治疗中的作用公开(公告)号:US20160256441A1
公开(公告)日:2016-09-08
申请号:US15029222
申请日:2014-10-16
Inventor: Eric M. SMALL , Eric N. OLSON
IPC: A61K31/42 , A61K9/08 , A61K9/14 , A61K45/06 , C07K16/18 , C12N15/113 , A61L17/00 , A61L17/06 , A61M1/00 , A61F13/00 , A61G10/02 , A61N1/04 , A61N5/06 , A61N7/00 , A61K9/06
CPC classification number: A61K31/42 , A61F13/00021 , A61G10/026 , A61K9/06 , A61K9/08 , A61K9/14 , A61K45/06 , A61L15/44 , A61L17/005 , A61L17/06 , A61L26/0066 , A61L2300/204 , A61L2300/412 , A61M1/0088 , A61N1/0468 , A61N5/062 , A61N7/00 , C07K16/18 , C12N15/113
Abstract: The present disclosure concerns uses for isoxazole compounds or salts or analogs thereof for the treatment of wounds. The present disclosure also concerns devices for delivering a isoxazole compound or salts or an analogs thereof to a wound site.
Abstract translation: 本公开涉及异恶唑化合物或其盐或类似物用于治疗伤口的用途。 本公开还涉及将异恶唑化合物或其盐或其类似物递送至伤口部位的装置。